Abstract
Two patients with extrapyramidal side effects after the use of fluphenazine decanoate were evaluated by means of IBZM-SPECT. Dopamine D2 receptor occupancy 1.5 months after withdrawal still amounted to 83% and 50%. More attention should be focused on long term effects of neuroleptics.
MeSH terms
-
Antipsychotic Agents / administration & dosage
-
Antipsychotic Agents / adverse effects*
-
Antipsychotic Agents / therapeutic use
-
Basal Ganglia Diseases / chemically induced
-
Basal Ganglia Diseases / physiopathology
-
Delayed-Action Preparations
-
Dopamine D2 Receptor Antagonists*
-
Female
-
Fluphenazine / adverse effects
-
Fluphenazine / analogs & derivatives
-
Fluphenazine / therapeutic use
-
Humans
-
Male
-
Middle Aged
-
Schizophrenia, Paranoid / complications
-
Schizophrenia, Paranoid / drug therapy
-
Tomography, Emission-Computed, Single-Photon
Substances
-
Antipsychotic Agents
-
Delayed-Action Preparations
-
Dopamine D2 Receptor Antagonists
-
fluphenazine depot
-
Fluphenazine